Biogen Inc. closed 41.04% below its 52-week high of $238.00, which the company achieved on July 12th.

Biogen enhances its portfolio and margins amidst market challenges and competition. Click here to find out why BIIB stock is ...

Jefferies analysts singled out the stocks that will be affected the most and the least by potential import taxes.

Eli Lilly (NYSE: LLY) has emerged as one of the hottest stocks in the GLP-1 realm -- underscored by its combination of ...

In return, Ionis will receive an undisclosed upfront payment from Sobi. It is also eligible to receive milestone payments and a tiered royalty on the drug's future sales.

Cambridge-based biotechnology company Biogen Inc. announced Monday that it will move its global headquarters to a new ...

Biogen Inc. (NASDAQ: BIIB) has unveiled plans for its new global headquarters in Cambridge, located across the Charles River from Boston. The biotechnology company has selected Kendall Common, located ...

In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Axsome Therapeutics (AXSM – Research Report), with a ...

The Cambridge City Council kickstarted a process to potentially raise linkage fees on commercial development on Monday, ...

Biogen Inc. closed 41.53% short of its 52-week high of $238.00, which the company achieved on July 12th.

With its move to MIT’s Volpe Center in Kendall Square, the drugmaker is consolidating its local footprint from three ...

Interleukin-23 inhibitors may be able to reduce the risk of developing psoriatic arthritis among patients with psoriasis, ...